Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (RHHVF)
OTHER OTC:RHHVF
Earnings Data
Report Date
Jan 29, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
10.71Last Year’s EPS
10.73Same Quarter Last Year
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call highlighted strong growth in pharmaceutical sales and robust pipeline development, particularly in oncology and neurology. However, challenges in the Diagnostics segment due to China's pricing reforms and mixed clinical trial results tempered the positive outlook. Additionally, regulatory setbacks and geopolitical uncertainties added caution.Company Guidance
Strong Overall Growth
Group sales increased by 7%, driven by a 10% growth in Pharma, with core operating profit growing by 11% and core EPS by 12%.
Pharmaceutical Achievements
EU approval of Itovebi and U.S. approval of Susvimo. Significant progress in the oncology and neurology segments, with Xolair and Ocrevus showing strong momentum.
Pipeline Development
Four new medicines moved into Phase III trials, with plans for more advancements. Positive Phase II data for fenebrutinib in MS and promising Phase II data for prasi in Parkinson's.
Diagnostics Innovation
Launch of new products including sequencing solutions and the Accu-Chek SmartGuide. Notable advancements in mass spectrometry and pathology assays.
RHHVF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RHHVF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 24, 2025 | $329.54 | $333.95 | +1.34% |
Jan 30, 2025 | $302.03 | $306.21 | +1.38% |
Jul 25, 2024 | $301.39 | $306.44 | +1.68% |
Feb 01, 2024 | $263.35 | $252.07 | -4.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Roche Holding AG (RHHVF) report earnings?
Roche Holding AG (RHHVF) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
What is Roche Holding AG (RHHVF) earnings time?
Roche Holding AG (RHHVF) earnings time is at Jan 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RHHVF EPS forecast?
RHHVF EPS forecast for the fiscal quarter 2025 (Q4) is 10.71.